Genomics represents a significant opportunity to unlock information that is not widely accessible to consumers, according to Illumina (NASDAQ:ILMN)(San Diego) CEO Jay Flatley, whose company is one of the top providers of gene-sequencing technology. The company has teamed up with New York-based private equity firm Warburg Pincus and venture capital firm Sutter Hill ventures to launch a consumer-focused genomics company called Helix (San Francisco), investing $100 million in seed money.